Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$826K Sell
2,349
-88
-4% -$31.4K 0.08% 114
2025
Q4
$798K Buy
2,437
+588
+32% +$187K 0.07% 106
2025
Q3
$522K Sell
1,849
-650
-26% -$189K 0.05% 129
2025
Q2
$698K Sell
2,499
-55
-2% -$15.6K 0.07% 110
2025
Q1
$796K Hold
2,554
0.08% 107
2024
Q4
$666K Hold
2,554
0.06% 116
2024
Q3
$823K Hold
2,554
0.08% 105
2024
Q2
$798K Hold
2,554
0.08% 104
2024
Q1
$726K Buy
2,554
+1,000
+64% +$293K 0.07% 105
2023
Q4
$448K Hold
1,554
0.05% 124
2023
Q3
$418K Buy
1,554
+244
+19% +$60.9K 0.05% 122
2023
Q2
$291K Sell
1,310
-96
-7% -$22.3K 0.03% 140
2023
Q1
$340K Buy
1,406
+96
+7% +$23.6K 0.04% 128
2022
Q4
$344K Hold
1,310
0.04% 127
2022
Q3
$295K Buy
1,310
+55
+4% +$13.3K 0.04% 129
2022
Q2
$305K Hold
1,255
0.04% 129
2022
Q1
$303K Hold
1,255
0.04% 140
2021
Q4
$282K Hold
1,255
0.03% 149
2021
Q3
$267K Hold
1,255
0.03% 151
2021
Q2
$306K Hold
1,255
0.04% 136
2021
Q1
$312K Buy
+1,255
New +$299K 0.04% 132
2020
Q4
Sell
-805
Closed -$205K 168
2020
Q3
$205K Buy
+805
New +$199K 0.04% 147
2019
Q2
Sell
-1,805
Closed -$343K 148
2019
Q1
$343K Hold
1,805
0.06% 106
2018
Q4
$351K Hold
1,805
0.07% 97
2018
Q3
$374K Hold
1,805
0.06% 97
2018
Q2
$333K Hold
1,805
0.07% 102
2018
Q1
$308K Buy
1,805
+390
+28% +$71.6K 0.06% 105
2017
Q4
$246K Sell
1,415
-17
-1% -$3.01K 0.05% 123
2017
Q3
$267K Buy
1,432
+40
+3% +$7.09K 0.06% 112
2017
Q2
$240K Hold
1,392
0.05% 123
2017
Q1
$228K Hold
1,392
0.05% 116
2016
Q4
$204K Hold
1,392
0.05% 106
2016
Q3
$232K Buy
1,392
+8
+0.6% +$1.35K 0.06% 96
2016
Q2
$211K Buy
+1,384
New +$215K 0.05% 106
2014
Q2
Sell
-2,192
Closed -$270K 104
2014
Q1
$270K Buy
2,192
+150
+7% +$18.2K 0.08% 76
2013
Q4
$233K Buy
2,042
+100
+5% +$11.4K 0.07% 85
2013
Q3
$217K Buy
+1,942
New +$211K 0.08% 85

Other funds holding AMGN

First Nebraska Trust's AMGN Position: Q1 2026 in Review

First Nebraska Trust reduced its Amgen (AMGN) stake by 3.6% in Q1 2026, selling an estimated $31.4K and leaving 2,349 shares worth $826K. The position accounts for 0.08% of the portfolio, ranked #114.

First Nebraska Trust first reported a position in AMGN in Q3 2013 and has held it in 37 quarters since. 3,127 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • First Nebraska Trust held 2,349 shares of Amgen worth $826K as of Q1 2026.
  • First Nebraska Trust sold 88 Amgen shares in Q1 2026, an estimated $31.4K.
  • Amgen made up 0.08% of First Nebraska Trust's portfolio in Q1 2026, its #114 holding.
  • First Nebraska Trust first reported a position in Amgen in Q3 2013 and has held it in 37 quarters since.
  • 3,127 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on First Nebraska Trust's 13F filing for Q1 2026, filed 1 Jun 2026.